» Articles » PMID: 6559061

HLA-linked Complement Polymorphisms (C2, BF) in Psoriasis

Overview
Specialty Dermatology
Date 1983 Jan 1
PMID 6559061
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Starting from the known association between psoriasis and several HLA antigens and from the fact that the HLA chromosomal region contains the structural genes for at least three complement components, the authors have looked for an association between psoriasis and allotypes of C2 and BF. C2 and BF polymorphism were examined in 230 psoriatic patients. Two rare complement genes were found to be significantly increased when compared with controls: the frequency of the C2*2 gene was 0.061 among patients and 0.035 among controls (P less than 0.05); for BF*SO7, the frequencies were 0.0304 in patients and 0.0092 in controls (P less than 0.0005). The BF*F gene frequency, however, was significantly decreased among patients: 0.1196 vs. 0.1743 (P less than 0.01). The relative risks were 1.79 for the C2 2, 3.44 for the BF SO7, and 0.6 for the BF F gene product. From previous studies, it is known that these three complement alleles (C2*2, BF*SO7, BF*F) are in linkage disequilibrium with HLA alleles that have also been found increased or decreased, respectively, in psoriasis.

Citing Articles

Discovering Genetic Factors for psoriasis through exhaustively searching for significant second order SNP-SNP interactions.

Lee K, Leung K, Tang N, Wong M Sci Rep. 2018; 8(1):15186.

PMID: 30315195 PMC: 6185942. DOI: 10.1038/s41598-018-33493-w.


DNA polymorphism of the C2 locus.

Bentley D, Campbell R, Cross S Immunogenetics. 1985; 22(4):377-90.

PMID: 2997031 DOI: 10.1007/BF00430921.


DNA polymorphism of the C2 and factor B genes. Detection of a restriction fragment length polymorphism which subdivides haplotypes carrying the C2C and factor B F alleles.

Cross S, Edwards J, Bentley D, Campbell R Immunogenetics. 1985; 21(1):39-48.

PMID: 2981769 DOI: 10.1007/BF00372240.


Correlation between HLA-A2-Bw46-DRw8 haplotype and increased levels of complement components (C4 and C4a) in patients with psoriatic arthritis.

Muto M, Mashimo M, Urabe K, Suzuki T, Sasazuki T Arch Dermatol Res. 1991; 283(5):347-9.

PMID: 1929558 DOI: 10.1007/BF00376626.


Study of HLA class I, class II and complement genes (C2, C4A, C4B and BF) in Japanese psoriatics and analysis of a newly-found high-risk haplotype by pulsed field gel electrophoresis.

Nakagawa H, Akazaki S, Asahina A, Tokunaga K, Matsuki K, Kuwata S Arch Dermatol Res. 1991; 283(5):281-4.

PMID: 1929549 DOI: 10.1007/BF00376613.

References
1.
White S, Newcomer V, Mickey M, Terasaki P . Disturbance of HL-A antigen frequency in Psoriasis. N Engl J Med. 1972; 287(15):740-3. DOI: 10.1056/NEJM197210122871504. View

2.
Mauff G, Federmann G, Hauptmann G . A hemolytically inactive gene product of factor B. Immunobiology. 1980; 158(1-2):96-100. DOI: 10.1016/S0171-2985(80)80047-7. View

3.
Mauff G, Adam R, Wachauf B, Hitzeroth H, Hiller C . Serum concentration and functional efficiency of factor B alleles. Immunobiology. 1980; 158(1-2):86-90. DOI: 10.1016/S0171-2985(80)80045-3. View

4.
Grosse-Wilde H, Wustner H, Albert E, Kuntz B, Scholz S, Braun-Falco O . HLA--D typing in 72 psoriasis vulgaris patients: distribution of seven HLA--D alleles. Tissue Antigens. 1978; 11(5):427-33. DOI: 10.1111/j.1399-0039.1978.tb01279.x. View

5.
Mauff G, Hummel K, Pulverer G . Properdin factor B (glycine-rich beta-glycoprotein or C3 proactivator)-polymorphism: genetic and biochemical aspects. First application to paternity cases. Z Immunitatsforsch Exp Klin Immunol. 1975; 150(4):327-38. View